Cargando…

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1

In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations ari...

Descripción completa

Detalles Bibliográficos
Autores principales: Feder, Alison F, Rhee, Soo-Yon, Holmes, Susan P, Shafer, Robert W, Petrov, Dmitri A, Pennings, Pleuni S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764592/
https://www.ncbi.nlm.nih.gov/pubmed/26882502
http://dx.doi.org/10.7554/eLife.10670
_version_ 1782417398910943232
author Feder, Alison F
Rhee, Soo-Yon
Holmes, Susan P
Shafer, Robert W
Petrov, Dmitri A
Pennings, Pleuni S
author_facet Feder, Alison F
Rhee, Soo-Yon
Holmes, Susan P
Shafer, Robert W
Petrov, Dmitri A
Pennings, Pleuni S
author_sort Feder, Alison F
collection PubMed
description In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations arise simultaneously, then adaptation proceeds by soft selective sweeps in which multiple adaptive mutations spread concomitantly, but if adaptive mutations occur rarely in the population, then a single adaptive mutation should spread alone in a hard selective sweep. Here, we use 6717 HIV-1 consensus sequences from patients treated with first-line therapies between 1989 and 2013 to confirm that the transition from fast to slow evolution of drug resistance was indeed accompanied with the expected transition from soft to hard selective sweeps. This suggests more generally that evolution proceeds via hard sweeps if resistance is unlikely and via soft sweeps if it is likely. DOI: http://dx.doi.org/10.7554/eLife.10670.001
format Online
Article
Text
id pubmed-4764592
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-47645922016-02-25 More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1 Feder, Alison F Rhee, Soo-Yon Holmes, Susan P Shafer, Robert W Petrov, Dmitri A Pennings, Pleuni S eLife Genomics and Evolutionary Biology In the early days of HIV treatment, drug resistance occurred rapidly and predictably in all patients, but under modern treatments, resistance arises slowly, if at all. The probability of resistance should be controlled by the rate of generation of resistance mutations. If many adaptive mutations arise simultaneously, then adaptation proceeds by soft selective sweeps in which multiple adaptive mutations spread concomitantly, but if adaptive mutations occur rarely in the population, then a single adaptive mutation should spread alone in a hard selective sweep. Here, we use 6717 HIV-1 consensus sequences from patients treated with first-line therapies between 1989 and 2013 to confirm that the transition from fast to slow evolution of drug resistance was indeed accompanied with the expected transition from soft to hard selective sweeps. This suggests more generally that evolution proceeds via hard sweeps if resistance is unlikely and via soft sweeps if it is likely. DOI: http://dx.doi.org/10.7554/eLife.10670.001 eLife Sciences Publications, Ltd 2016-02-14 /pmc/articles/PMC4764592/ /pubmed/26882502 http://dx.doi.org/10.7554/eLife.10670 Text en © 2016, Feder et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Genomics and Evolutionary Biology
Feder, Alison F
Rhee, Soo-Yon
Holmes, Susan P
Shafer, Robert W
Petrov, Dmitri A
Pennings, Pleuni S
More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
title More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
title_full More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
title_fullStr More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
title_full_unstemmed More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
title_short More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
title_sort more effective drugs lead to harder selective sweeps in the evolution of drug resistance in hiv-1
topic Genomics and Evolutionary Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764592/
https://www.ncbi.nlm.nih.gov/pubmed/26882502
http://dx.doi.org/10.7554/eLife.10670
work_keys_str_mv AT federalisonf moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1
AT rheesooyon moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1
AT holmessusanp moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1
AT shaferrobertw moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1
AT petrovdmitria moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1
AT penningspleunis moreeffectivedrugsleadtoharderselectivesweepsintheevolutionofdrugresistanceinhiv1